TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy
暂无分享,去创建一个
E. Antman | R. Giugliano | D. Morrow | A. Charlesworth | Richard Cairns | S. Murphy | J. D. de Lemos | C. McCabe | E. Braunwald | C. Mccabe
[1] P. Brandt,et al. A new coronary prognostic index. , 1969, American heart journal.
[2] G. Sanz,et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. , 1982, The New England journal of medicine.
[3] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[4] J. Fleiss,et al. Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.
[5] A. Albert,et al. Short‐term risk stratification at admission based on simple clinical data in acute myocardial infarction , 1989, The American journal of cardiology.
[6] D Draper,et al. Predicting hospital-associated mortality for Medicare patients. A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure. , 1988, JAMA.
[8] E. Braunwald,et al. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. , 1990, Journal of the American College of Cardiology.
[9] W. O’Neill,et al. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. , 1991, Annals of internal medicine.
[10] P. Kudenchuk,et al. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention Project). , 1993, The American journal of cardiology.
[11] E. Negri,et al. Determinants of 6‐Month Mortality in Survivors of Myocardial Infarction After Thrombolysis Results of the GISSI‐2 Data Base , 1993, Circulation.
[12] Johan Herlitz,et al. Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .
[13] C. Fry,et al. Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.
[14] Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994, The Lancet.
[15] Fibrinolytictherapytrialistsf. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .
[16] E. Antman. Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial. , 1994, Circulation.
[17] J Col,et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. , 1995, Circulation.
[18] U Ludwigs,et al. Acute Physiology and Chronic Health Evaluation II scoring system in acute myocardial infarction: a prospective validation study. , 1995, Critical care medicine.
[19] E. Antman. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. , 1996, Circulation.
[20] J. Rouleau,et al. Myocardial infarction patients in the 1990s--their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. , 1996, Journal of the American College of Cardiology.
[21] B. McNeil,et al. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the Cooperative Cardiovascular Project. , 1996, JAMA.
[22] C. Naylor,et al. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. , 1996, Journal of the American College of Cardiology.
[23] R. Califf,et al. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. , 1996, Journal of the American College of Cardiology.
[24] E. Topol. Textbook of Cardiovascular Medicine , 1997 .
[25] A. Rebuzzi,et al. Need for a composite risk stratification of patients with unstable coronary syndromes tailored to clinical practice. , 1997, Circulation.
[26] J. Gore,et al. Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) Participants. , 1998, American heart journal.
[27] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.
[28] D. Jacobs,et al. PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota heart survey. , 1999, Circulation.
[29] H. Krumholz,et al. Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment. , 1999, Circulation.
[30] E. Antman,et al. The length of the hospital stay after myocardial infarction. , 2000, The New England journal of medicine.